Sültmann Holger, Poustka Annemarie
German Cancer Research Center, Division of Molecular Genome Analysis, Im Neuenheimer Feld 580, D-69120 Heidelberg, Germany.
Curr Opin Mol Ther. 2004 Dec;6(6):593-9.
During the past 20 years, significant success in the therapy of certain cancer types has given rise to the hope that cancer will soon be curable. However, survival rates of most patients diagnosed with cancer have not substantially increased. Instead, it is becoming clear that many tumor types, which were previously regarded as homogeneous disease entities, are composed of different subtypes which lead to varying patient prognosis and survival rates. These findings complicate diagnosis and treatment of cancer patients and call for new anti-oncogenic therapies. DNA microarrays are powerful tools to investigate global gene expression in tumors and their corresponding normal tissues, to classify tumors based on their molecular properties, and to identify novel targets for future tumor therapy. Recent results of global gene expression analyses in various tumor types are reviewed, and their implications for diagnosis and therapy of human cancer are discussed.
在过去20年里,某些癌症类型的治疗取得了显著成功,这让人们燃起了癌症不久将可治愈的希望。然而,大多数被诊断患有癌症的患者的生存率并未大幅提高。相反,越来越明显的是,许多以前被视为同质疾病实体的肿瘤类型,实际上是由不同的亚型组成,这些亚型导致患者的预后和生存率各不相同。这些发现使癌症患者的诊断和治疗变得复杂,需要新的抗癌疗法。DNA微阵列是研究肿瘤及其相应正常组织中整体基因表达、根据分子特性对肿瘤进行分类以及识别未来肿瘤治疗新靶点的强大工具。本文综述了各种肿瘤类型中整体基因表达分析的最新结果,并讨论了它们对人类癌症诊断和治疗的意义。